Target intelligence / Profile preview

40S ribosomal protein S29 (RPS29)

Target
RPS29
Molecular classification
Ribosomal protein, Component of small ribosomal subunit, S14P family
01

Overview

40S ribosomal protein S29 (RPS29) is a structural component of the 40S small ribosomal subunit, encoded by the RPS29 gene on chromosome 14[1][2][4]. It contains a C2–C2 zinc finger-like domain important for zinc binding and the integrity of the ribosome[2][3][6]. This protein is required for proper ribosomal assembly and efficient protein synthesis within the cytoplasm[2][3][5]. RPS29 can enhance the tumor suppressor activity of Ras-related protein 1A (KREV1)[2][3][5]. Mutations in RPS29 are causative for Diamond-Blackfan anemia subtype 13, a rare congenital erythroid aplasia; altered expression has been observed in some cancers, though its expression level does not correlate with disease severity[1][2][3]. RPS29 is not known to be a direct therapeutic target or to interact with drugs, and no known biomarkers or direct safety concerns have been recorded.

Other names
Small ribosomal subunit protein uS14S29uS14DBA13ribosomal protein S29
02

Biological functions

Protein synthesis (structural constituent of ribosome)Zinc ion bindingEnhancement of tumor suppressor activity (KREV1 interaction)
03

Disease associations

Diamond-Blackfan anemiaCancer (notably variable expression in colorectal cancer, but not shown as direct disease driver)

Beyond the preview

Go deeper on 40S ribosomal protein S29 (RPS29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 40S ribosomal protein S29 (RPS29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call